Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michihiro Hide

Showing results (211-220 of 287) with videos related to

Pageof 29
Sort By:
Allergology International : Official Journal of the Japanese Society of Allergology|September 26, 2024
Long term safety and efficacy of ligelizumab in the treatment of Japanese patients with chronic spontaneous urticariaHidetoshi Takahashi, Atsushi Fukunaga, Koremasa Hayama, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 4, 2019
Long-term dynamics of omega-5 gliadin-specific IgE levels in patients with adult-onset wheat allergyYuto Hamada, Yuko Chinuki, Yuma Fukutomi, et al.
European Journal of Hospital Pharmacy : Science and Practice|March 6, 2020
Three cases of advanced cutaneous squamous cell carcinoma treated with a combination of carboplatin and epirubicinMayumi Okamoto, Takanobu Kan, Emi Murakami, et al.
The Journal of Dermatology|August 31, 2023
English version of Japanese guidance for biologics in treating atopic dermatitisHidehisa Saeki, Masashi Akiyama, Masatoshi Abe, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|March 1, 2023
Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 studyTomoo Fukuda, Keiko Yamagami, Kimito Kawahata, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|May 23, 2021
A validation study of the Japanese version of the Angioedema Activity Score (AAS) and the Angioedema Quality of Life Questionnaire (AE-QoL)Satoshi Morioke, Shunsuke Takahagi, Reo Kawano, et al.
Journal of Dermatological Science|February 10, 2021
Gender disparities in academic dermatology in Japan: Results from the first national surveyMari Kishibe, Yasuaki Saijo, Satomi Igawa, et al.
The World Allergy Organization Journal|March 6, 2024
Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trialDaisuke Honda, Michihiro Hide, Tomoo Fukuda, et al.
The Journal of Dermatology|November 1, 2025
Disease Duration of Urticaria: A Sub-Analysis of a Survey on Subtypes and Clinical Characteristics of 1061 Patients With Urticaria in the Primary Care Institutes in JapanRyo Saito, Kiyoshi Furutani, Shoji Mihara, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|January 14, 2023
Efficacy and safety of omalizumab in adult patients with wheat-dependent exercise-induced anaphylaxis: Reduction of in vitro basophil activation and allergic reaction to wheatYuko Chinuki, Kunie Kohno, Michihiro Hide, et al.
Pageof 29

Showing results (211-220 of 287) with videos related to

Sort By:
Pageof 29
Allergology International : Official Journal of the Japanese Society of Allergology|September 26, 2024
Long term safety and efficacy of ligelizumab in the treatment of Japanese patients with chronic spontaneous urticariaHidetoshi Takahashi, Atsushi Fukunaga, Koremasa Hayama, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 4, 2019
Long-term dynamics of omega-5 gliadin-specific IgE levels in patients with adult-onset wheat allergyYuto Hamada, Yuko Chinuki, Yuma Fukutomi, et al.
European Journal of Hospital Pharmacy : Science and Practice|March 6, 2020
Three cases of advanced cutaneous squamous cell carcinoma treated with a combination of carboplatin and epirubicinMayumi Okamoto, Takanobu Kan, Emi Murakami, et al.
The Journal of Dermatology|August 31, 2023
English version of Japanese guidance for biologics in treating atopic dermatitisHidehisa Saeki, Masashi Akiyama, Masatoshi Abe, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|March 1, 2023
Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 studyTomoo Fukuda, Keiko Yamagami, Kimito Kawahata, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|May 23, 2021
A validation study of the Japanese version of the Angioedema Activity Score (AAS) and the Angioedema Quality of Life Questionnaire (AE-QoL)Satoshi Morioke, Shunsuke Takahagi, Reo Kawano, et al.
Journal of Dermatological Science|February 10, 2021
Gender disparities in academic dermatology in Japan: Results from the first national surveyMari Kishibe, Yasuaki Saijo, Satomi Igawa, et al.
The World Allergy Organization Journal|March 6, 2024
Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trialDaisuke Honda, Michihiro Hide, Tomoo Fukuda, et al.
The Journal of Dermatology|November 1, 2025
Disease Duration of Urticaria: A Sub-Analysis of a Survey on Subtypes and Clinical Characteristics of 1061 Patients With Urticaria in the Primary Care Institutes in JapanRyo Saito, Kiyoshi Furutani, Shoji Mihara, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|January 14, 2023
Efficacy and safety of omalizumab in adult patients with wheat-dependent exercise-induced anaphylaxis: Reduction of in vitro basophil activation and allergic reaction to wheatYuko Chinuki, Kunie Kohno, Michihiro Hide, et al.
Pageof 29